RGNX
Regenxbio Inc
7.40$
+2.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.2% | -296.7% | -1,058.1% | -558.0% | 47.9% | -305.7% | -35.0% | 46.5% | -184.1% | -242.0% | -207.8% | -72.7% | |
| 1.3% | 1.1% | 11.9% | 25.8% | 1.8% | 20.3% | 5.4% | 2.0% | 11.5% | 19.2% | 19.5% | 9.2% | |
| 5.2% | 38.5% | 153.2% | 102.0% | 7.6% | 76.2% | 20.7% | 8.3% | 36.2% | 44.6% | 46.2% | 20.3% | |
| 8.1% | 42.9% | 188.2% | 111.6% | 7.6% | 60.0% | 26.2% | 8.8% | 40.8% | – | – | – | |
| 18.1% | -40.1% | 113.9% | 8.6% | -3.6% | -15.1% | 9.2% | 8.6% | 12.4% | -12.1% | 6.6% | 6.9% | |
| 8.5% | 6.9% | 177.6% | 68.9% | 6.1% | 33.3% | 17.4% | 17.9% | 27.3% | 11.0% | 2.9% | 1.4% | |
| -2,676.5% | -2,158.7% | 417.6% | -46.1% | -127.8% | 265.5% | 79.4% | -86.5% | -10.6% | 211.6% | 124.1% | -9.3% | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 0.0% | 3,153.8% | 3.9% | 5.3% | 0.4% | 3.7% | 1.2% | 0.0% | -0.3% | -0.5% | 1.4% | 0.6% | |
| 39.2% | – | – | – | – | – | – | – | – | – | 0.0% | 84.8% | |
| 39.2% | 3,153.8% | 2.6% | 814.0% | 93.6% | 23.8% | 129.5% | 41.5% | -25.6% | -38.7% | 111.2% | 68.5% | |
| 0.0% | 698.4% | -638.0% | 209.9% | 13.6% | -16.4% | 174.0% | 1.6% | -220.2% | -69.2% | 27.6% | -13.5% | |
| -39.2% | -303.6% | -1,235.7% | -626.9% | 41.8% | -339.0% | -52.4% | 28.6% | -211.3% | -253.1% | -210.7% | -74.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.